Tyers Asset Management’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$14K Hold
944
﹤0.01% 975
2019
Q2
$19K Sell
944
-864
-48% -$14.3K ﹤0.01% 962
2019
Q1
$30K Hold
1,808
﹤0.01% 944
2018
Q4
$25K Sell
1,808
-15,792
-90% -$209K ﹤0.01% 911
2018
Q3
$308K Buy
17,600
+784
+5% +$15K 0.01% 630
2018
Q2
$306K Sell
16,816
-1,504
-8% -$25.5K 0.01% 565
2018
Q1
$344K Buy
+18,320
New +$357K 0.01% 518

Other funds holding KURA

Tyers Asset Management's KURA Position: Q3 2019 in Review

Tyers Asset Management held its Kura Oncology (KURA) position steady in Q3 2019 at 944 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #975.

Tyers Asset Management first reported a position in KURA in Q1 2018 and has held it in 7 quarters since. The position peaked at $344K in Q1 2018. 116 funds tracked by Wall St. Rank hold KURA as of Q3 2019.

  • Tyers Asset Management held 944 shares of Kura Oncology worth $14K as of Q3 2019.
  • Tyers Asset Management left its Kura Oncology share count unchanged in Q3 2019.
  • Kura Oncology made up ﹤0.01% of Tyers Asset Management's portfolio in Q3 2019, its #975 holding.
  • Tyers Asset Management first reported a position in Kura Oncology in Q1 2018 and has held it in 7 quarters since.
  • Tyers Asset Management's Kura Oncology position peaked at $344K in Q1 2018.
  • 116 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.